Novo Nordisk Seeks FDA Approval For Higher Dose of Wegovy Weight-Loss Shot

Novo Nordisk NOVO.B 4.42%increase; green up pointing triangle filed for U.S. approval of a higher dose of its Wegovy weight-loss injection, with a decision expected within a month or two.

The Danish drugmaker submitted an application for Wegovy 7.2 milligrams, with the Food and Drug Administration set to review the application under its priority voucher program that seeks to accelerate the review of products that address major health priorities.